Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
May 28, 2009

MDS Nordion Opens Glucotrace Facility in Belgium

MDS Nordion Opens Glucotrace Facility in Belgium

Belgian facility will supply Northwest Europe

  • MDS Nordion is opening a facility in Fleurus, Belgium for the production of Glucotrace a radiopharmaceutical used in PET imaging. The new facility will provide Glucotrace for hospitals in Belgium, France, Germany, Luxembourg, and The Netherlands.

    "Our investment in this facility further demonstrates our commitment to address the growing demand for PET diagnostic imaging in targeted European regions, and provides the medical community greater service for their future patient care," says Steve West, the president of MDS Nordion.

    The company says that due to projected increasing demand in Europe for PET, the new production facility will have three daily production runs and a customer service team available 24 hours a day, seven days a week.

    On May 19, MDS Nordion announced that a heavy water leak at the reactor of its primary supplier would likely result in a significant shortage of medical radioisotopes worldwide.ADNFCR-2184-ID-19190842-ADNFCR

Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »